Besides liver enzymes, which laboratory test should be monitored to assess hematologic effects during valproic acid therapy?

Prepare for the EDAPT Intracranial Regulation Test with interactive flashcards and multiple choice questions. Each question is accompanied by helpful hints and explanations to boost your readiness. Get started today and ensure your success!

Multiple Choice

Besides liver enzymes, which laboratory test should be monitored to assess hematologic effects during valproic acid therapy?

Explanation:
Hematologic safety with valproic acid hinges on detecting effects on the blood cells, including anemia, leukopenia, and especially thrombocytopenia. A complete blood count directly measures red cells, white cells, and platelets, so it can reveal decreases in any of these components and flag bleeding risk if platelets are low. While liver enzymes monitor liver injury, and urinalysis or creatinine clearance assess kidney-related issues, none specifically track blood cell status. Thus, the complete blood count is the most appropriate test to monitor hematologic effects during valproic acid therapy.

Hematologic safety with valproic acid hinges on detecting effects on the blood cells, including anemia, leukopenia, and especially thrombocytopenia. A complete blood count directly measures red cells, white cells, and platelets, so it can reveal decreases in any of these components and flag bleeding risk if platelets are low. While liver enzymes monitor liver injury, and urinalysis or creatinine clearance assess kidney-related issues, none specifically track blood cell status. Thus, the complete blood count is the most appropriate test to monitor hematologic effects during valproic acid therapy.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy